Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 112251-112300 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT02804022
Vital-signs-integrated Patient-assisted Intravenous Opioid Analgesia
PHASE2Active, not recruiting
20 participants
Started: Dec 29, 2016 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT03177577
Strengthening of the First Dorsal Interosseous for Thumb Carpometacarpal Osteoarthritis
NARecruiting
30 participants
Started: Dec 29, 2016 · Completed: Sep 30, 2025
2 conditions1 sponsor1 location
NCT03010150
Blood Tests and Questionnaires in Studying Adherence to Preventative Swallowing Exercises in Participants With Metastatic Head and Neck Cancer
N/ARecruiting
471 participants
Started: Dec 29, 2016 · Completed: Dec 31, 2028
31 conditions2 sponsors1 location
NCT03494374
The Effect of Orthosis and Exercise in Pes Planus
NARecruiting
200 participants
Started: Dec 29, 2016 · Completed: Nov 29, 2026
1 condition1 sponsor1 location
NCT02546661
Open-Label, Randomised, Multi-Drug, Biomarker-Directed, Phase 1b Study in Pts w/ Muscle Invasive Bladder Cancer
PHASE1Active, not recruiting
117 participants
Started: Dec 28, 2016 · Completed: Jan 9, 2026
1 condition1 sponsor27 locations
NCT02933489
Abbreviated Breast MRI and Digital Tomosynthesis Mammography in Screening Women With Dense Breasts
NAActive, not recruiting
1,516 participants
Started: Dec 27, 2016 · Completed: Dec 31, 2025
1 condition2 sponsors68 locations
NCT02960022
A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
PHASE2Recruiting
900 participants
Started: Dec 22, 2016 · Completed: Jul 31, 2029
1 condition2 sponsors236 locations
NCT03333187
Ruxolitinib vs Allogeneic SCT for Patients With Myelofibrosis According to Donor Availability
PHASE2Active, not recruiting
87 participants
Started: Dec 21, 2016 · Completed: Oct 7, 2025
1 condition3 sponsors14 locations
NCT03033446
Study of Y90-Radioembolization With Nivolumab in Asians With Hepatocellular Carcinoma
PHASE2Active, not recruiting
40 participants
Started: Dec 20, 2016 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT02940301
Ibrutinib and Nivolumab in Treating Patients With Relapsed or Refractory Classical Hodgkin Lymphoma
PHASE2Active, not recruiting
18 participants
Started: Dec 20, 2016 · Completed: Feb 15, 2026
1 condition1 sponsor2 locations
NCT02989584
A Phase II Study of Atezolizumab in Combination With Cisplatin + Gemcitabine Before Surgery to Remove the Bladder Cancer
PHASE1/PHASE2Active, not recruiting
54 participants
Started: Dec 20, 2016 · Completed: Dec 31, 2025
3 conditions2 sponsors11 locations
NCT02917993
An Open-Label Phase 1/2 Study of Itacitinib in Combination With Osimertinib in Subjects With Non-Small Cell Lung Cancer
PHASE1/PHASE2Active, not recruiting
59 participants
Started: Dec 20, 2016 · Completed: Dec 31, 2025
1 condition2 sponsors31 locations
NCT02917421
Accelerated Radiation Therapy (ART) to the Breast and Nodal Stations
PHASE1/PHASE2Active, not recruiting
88 participants
Started: Dec 19, 2016 · Completed: Dec 31, 2026
1 condition1 sponsor3 locations
NCT02979873
Sirolimus (Rapamune ) for Relapse Prevention in People With Severe Aplastic Anemia Responsive to Immunosuppressive Therapy
PHASE2Active, not recruiting
84 participants
Started: Dec 19, 2016 · Completed: Jun 30, 2030
1 condition1 sponsor1 location
NCT02979483
Management of Symptomatic Advanced Pancreatic Adenocarcinoma
NAActive, not recruiting
110 participants
Started: Dec 19, 2016 · Completed: Sep 30, 2025
2 conditions1 sponsor12 locations
NCT03131817
Cortical Stimulation to Treat Mood and Behavioral Symptoms in Parkinson's Disease Patients
NAActive, not recruiting
10 participants
Started: Dec 16, 2016 · Completed: Dec 16, 2030
1 condition1 sponsor1 location
NCT04547582
Spinal Cord Stimulation for Restoration of Function in Lower-Limb Amputees, 90-Day
NAActive, not recruiting
10 participants
Started: Dec 16, 2016 · Completed: Aug 31, 2027
2 conditions2 sponsors1 location
NCT02696993
Nivolumab and Radiation Therapy With or Without Ipilimumab in Treating Patients With Brain Metastases From Non-small Cell Lung Cancer
PHASE1/PHASE2Active, not recruiting
80 participants
Started: Dec 16, 2016 · Completed: Dec 31, 2027
2 conditions1 sponsor1 location
NCT06473259
Evaluation of Clinical Outcomes of Chemotherapy or Androgen-receptor Targeting Agent (Alone or Combined) or Radiotherapy on Primary Tumor in Addition to Androgen Deprivation Therapy in HOrmone-Sensitive Metastatic Prostate Cancer Patients
N/ARecruiting
3,000 participants
Started: Dec 16, 2016 · Completed: Dec 31, 2028
3 conditions1 sponsor3 locations
NCT02808780
An Observational Prospective Long-term Exposure Registry of Adult Patients With Moderate-to-Severe Ulcerative Colitis
N/AActive, not recruiting
537 participants
Started: Dec 16, 2016 · Completed: Mar 11, 2027
1 condition1 sponsor63 locations
NCT03327428
Sickle-cell Disease Registry of the GPOH
N/ARecruiting
1,000 participants
Started: Dec 15, 2016 · Completed: Dec 31, 2040
1 condition9 sponsors1 location
NCT02993900
Image-Guided Gynecologic Brachytherapy
NARecruiting
54 participants
Started: Dec 15, 2016 · Completed: Dec 31, 2028
5 conditions2 sponsors1 location
NCT02934568
Ribociclib (LEE011) Rollover Study for Continued Access
PHASE2Recruiting
50 participants
Started: Dec 15, 2016 · Completed: Sep 1, 2026
1 condition1 sponsor13 locations
NCT02996877
Outcomes of Surgically Ineligible Patients With Multivessel CAD
N/AActive, not recruiting
750 participants
Started: Dec 15, 2016 · Completed: Jul 31, 2025
1 condition2 sponsors21 locations
NCT05706558
Retrospective Review of Esophageal Cancer at MSKCC
N/ARecruiting
4,000 participants
Started: Dec 13, 2016 · Completed: Feb 28, 2026
2 conditions1 sponsor1 location
NCT03006172
To Evaluate the Safety, Tolerability, and Pharmacokinetics of Inavolisib Single Agent in Participants With Solid Tumors and in Combination With Endocrine and Targeted Therapies in Participants With Breast Cancer
PHASE1Active, not recruiting
200 participants
Started: Dec 13, 2016 · Completed: Dec 31, 2026
2 conditions1 sponsor10 locations
NCT03626194
Prospective Evaluation of the Efficacy and Safety of Endoscopic Tissue Apposition
N/ARecruiting
500 participants
Started: Dec 12, 2016 · Completed: Dec 16, 2026
6 conditions1 sponsor1 location
NCT02737046
Belinostat Therapy With Zidovudine for Adult T-Cell Leukemia-Lymphoma
PHASE2Active, not recruiting
15 participants
Started: Dec 12, 2016 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT02872025
Immunotherapy in High-risk Ductal Carcinoma in Situ (DCIS)
EARLY_PHASE1Active, not recruiting
42 participants
Started: Dec 12, 2016 · Completed: Mar 31, 2026
1 condition3 sponsors1 location
NCT02974595
Natural History, Pathogenesis, and Outcome of Autoinflammatory Diseases (NOMID/CAPS, DIRA, CANDLE, SAVI, NLRC4-MAS, Still'S-like Diseases, and Other Undifferentiated Autoinflammatory Diseases)
N/ARecruiting
3,200 participants
Started: Dec 9, 2016 · Completed: Sep 30, 2032
5 conditions1 sponsor1 location
NCT02685605
Intraoperative Radiotherapy in Newly Diagnosed Glioblastoma Multiforme
PHASE3Active, not recruiting
314 participants
Started: Dec 9, 2016 · Completed: Jun 30, 2026
1 condition3 sponsors19 locations
NCT02910700
Nivolumab With Trametinib and Dabrafenib, or Encorafenib and Binimetinib in Treating Patients With BRAF Mutated Metastatic or Unresectable Stage III-IV Melanoma
PHASE2Active, not recruiting
52 participants
Started: Dec 9, 2016 · Completed: Dec 8, 2025
8 conditions2 sponsors1 location
NCT01422759
Effect of Spironolactone on Adrenal or Ovarian Androgen Production in Overweight Pubertal Girls With Androgen Excess
NARecruiting
20 participants
Started: Dec 9, 2016 · Completed: Dec 31, 2024
3 conditions1 sponsor1 location
NCT03047369
The Myelin Disorders Biorepository Project
N/ARecruiting
12,000 participants
Started: Dec 8, 2016 · Completed: Dec 8, 2030
66 conditions21 sponsors23 locations
NCT02639299
Screening of Healthy Volunteers for Investigational Antimalarial Drugs, Malaria Vaccines, and Controlled Human Malaria Challenge
N/ARecruiting
1,500 participants
Started: Dec 8, 2016 · Completed: Sep 30, 2030
1 condition1 sponsor1 location
NCT02974738
A Trial of Belzutifan (PT2977, MK-6482) Tablets In Patients With Advanced Solid Tumors (MK-6482-001)
PHASE1Active, not recruiting
120 participants
Started: Dec 7, 2016 · Completed: Apr 14, 2027
16 conditions1 sponsor0 locations
NCT03633253
"The Motoric Cognitive Risk Syndrome in the Quebec Population"
N/AActive, not recruiting
1,741 participants
Started: Dec 7, 2016 · Completed: Dec 7, 2025
2 conditions1 sponsor1 location
NCT02843191
Consolidation Chemotherapy for Locally Advanced Mid or Low Rectal Cancer After Neoadjuvant Concurrent Chemoradiotherapy
PHASE3Active, not recruiting
358 participants
Started: Dec 7, 2016 · Completed: Jun 30, 2026
1 condition6 sponsors14 locations
NCT02973412
Chronotype of Patients With Diabetes and Effect on Glycaemic Control
N/ARecruiting
3,447 participants
Started: Dec 7, 2016 · Completed: Dec 31, 2027
2 conditions2 sponsors1 location
NCT02942355
Trial of Anastrozole and Palbociclib in Metastatic HER2-Negative Breast Cancer
PHASE2Active, not recruiting
40 participants
Started: Dec 7, 2016 · Completed: Jun 30, 2026
2 conditions3 sponsors1 location
NCT03382158
International PPB/DICER1 Registry
N/ARecruiting
3,400 participants
Started: Dec 6, 2016 · Completed: Dec 6, 2035
19 conditions44 sponsors1 location
NCT04050345
Tracking Mutations in Cell Free Tumour DNA to Predict Relapse in Early Colorectal Cancer
N/ARecruiting
1,000 participants
Started: Dec 5, 2016 · Completed: Jul 31, 2031
1 condition1 sponsor71 locations
NCT03494946
Liver Transplantation Compared to Chemotherapy in Patients With ColoRectal Cancer
NARecruiting
30 participants
Started: Dec 5, 2016 · Completed: Jan 31, 2027
2 conditions1 sponsor1 location
NCT05976841
SEDVasc (RaDiCo Cohort) (RaDiCo-SEDVasc)
N/AActive, not recruiting
340 participants
Started: Dec 5, 2016 · Completed: Jan 31, 2028
1 condition1 sponsor17 locations
NCT02763566
A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer
PHASE3Active, not recruiting
463 participants
Started: Dec 5, 2016 · Completed: Jan 31, 2027
1 condition1 sponsor45 locations
NCT02840448
Impact of Elastin Mediated Vascular Stiffness on End Organs
N/ARecruiting
218 participants
Started: Dec 2, 2016 · Completed: Feb 25, 2032
3 conditions1 sponsor2 locations
NCT02919644
Vaccination with Autologous Dendritic Cells Loaded with Autologous Tumour Homogenate After Curative Resection for Stage IV Colorectal Cancer.
PHASE2Recruiting
19 participants
Started: Dec 2, 2016 · Completed: Dec 31, 2031
2 conditions1 sponsor2 locations
NCT04087200
Protective Effect of Early High Dose stATins On Cardiovascular and Renal Events in Acute Coronary Syndrome
N/ARecruiting
2,500 participants
Started: Dec 1, 2016 · Completed: Dec 1, 2026
1 condition2 sponsors1 location
NCT02997254
COMParison of Algorithms for Rotational Evaluation in Atrial Fibrillation
N/ARecruiting
200 participants
Started: Dec 1, 2016 · Completed: Nov 30, 2026
2 conditions1 sponsor1 location
NCT02998411
Population Pharmacokinetics of Anti-infectives in Hospitalized Patients
N/ARecruiting
60 participants
Started: Dec 1, 2016 · Completed: Dec 31, 2028
1 condition1 sponsor1 location